State-dependent Ras signaling and AMPA receptor trafficking

  1. Yi Qin1,3,5,6,
  2. Yinghua Zhu1,5,
  3. Joel P. Baumgart1,2,5,
  4. Ruth L. Stornetta1,
  5. Kenneth Seidenman3,
  6. Volker Mack4,
  7. Linda van Aelst3, and
  8. J. Julius Zhu1,2,7
  1. 1Department of Pharmacology and 2Neuroscience Graduate Program, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA; 3Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA; 4Department of Molecular Neurobiology, Max Planck Institute for Medical Research, Heidelberg D-69120, Germany

Abstract

Synaptic trafficking of AMPA-Rs, controlled by small GTPase Ras signaling, plays a key role in synaptic plasticity. However, how Ras signals synaptic AMPA-R trafficking is unknown. Here we show that low levels of Ras activity stimulate extracellular signal-regulated kinase kinase (MEK)–p42/44 MAPK (extracellular signal-regulated kinase [ERK]) signaling, whereas high levels of Ras activity stimulate additional Pi3 kinase (Pi3K)–protein kinase B (PKB) signaling, each accounting for ∼50% of the potentiation during long-term potentiation (LTP). Spontaneous neural activity stimulates the Ras–MEK–ERK pathway that drives GluR2L into synapses. In the presence of neuromodulator agonists, neural activity also stimulates the Ras–Pi3K–PKB pathway that drives GluR1 into synapses. Neuromodulator release increases with increases of vigilance. Correspondingly, Ras–MEK–ERK activity in sleeping animals is sufficient to deliver GluR2L into synapses, while additional increased Ras–Pi3K–PKB activity in awake animals delivers GluR1 into synapses. Thus, state-dependent Ras signaling, which specifies downstream MEK–ERK and Pi3K–PKB pathways, differentially control GluR2L- and GluR1-dependent synaptic plasticity.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.342205.

  • 5 These authors contributed equally or significantly to this work.

  • 6 Present address: Center for Cell Signaling, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

  • 7 Corresponding author.

    7 E-MAIL jjzhu{at}virginia.edu; FAX (434) 982-3878.

    • Accepted July 5, 2005.
    • Received February 15, 2005.
| Table of Contents

Life Science Alliance